Stock listing

BX Swiss:NWRN Newron Pharmaceuticals S.p.A. Aktie

Swiss listing (BX Swiss) of Newron Pharmaceuticals S.p.A. · home listing SIX Swiss:NWRN

Follow Newron Pharmaceuticals S.p.A. into a list and get an email when it puts out news.

Home listing price · SIX:NWRN

8.84 CHF -0.16 (-1.8%)

Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, SIX:NWRN

Past year -37.3% · daily closes, Nov 3, 2025 – Nov 2, 2026, adjusted for splits
Day range
8.80 – 9.02 CHFNov 2, 2026
Volume
21,247 sharesNov 2, 2026
Market cap
180.8M CHFAt the close on Nov 2, 2026 · price × 20.45M shares outstanding
52-week range
5.72 – 31.85 CHFLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
Traded on an average day
696,274 CHFMedian day 50,625 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Newron Pharmaceuticals S.p.A. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
SIX Swiss:NWRN · Home8.84 CHF-0.16 (-1.8%)21,2479.029.028.809.00Close on Nov 2, 2026
Xetra:NP5€9.60 EUR+0.12 (+1.3%)1,724€9.84€10.00€9.48€9.48Close on Oct 27, 2026
LSE:0QOI8.73 CHF-0.03 (-0.3%)1,2319.019.018.738.76Close on Oct 27, 2026
Frankfurt:NP5€9.50 EUR-0.22 (-2.3%)—€9.64€9.64€9.50€9.72Close on Oct 30, 2026

Daily closes

Last 3 months, Aug 3, 2026 – Nov 2, 2026 · SIX:NWRN · CHF, adjusted for splits

DayCloseChange%OpenHighLowVolume
8.84-0.16-1.8%9.029.028.8021,247
9.00-0.13-1.4%9.209.208.8040,268
9.13+0.29+3.3%8.859.408.8162,206
8.84-0.14-1.6%9.039.238.7353,306
8.98-0.12-1.3%9.209.288.6850,546
9.10+0.46+5.3%8.719.198.6461,599
8.64-0.04-0.5%8.688.788.4835,077
8.68+0.18+2.1%8.628.688.2460,069
8.500.000.0%8.608.628.3545,756
8.50+0.53+6.6%8.008.558.0038,642
7.97-0.23-2.8%8.208.297.9038,250
8.20+0.01+0.1%8.318.638.1579,760
8.19+0.23+2.9%7.908.267.9053,292
7.96+0.56+7.6%7.408.047.4068,090
7.40-0.57-7.2%8.108.177.4092,387
7.97+0.38+5.0%7.658.217.55104,563
7.59+0.38+5.3%7.407.907.4092,896
7.21-0.24-3.2%6.007.405.72221,546
7.45-0.27-3.5%7.577.707.30104,914
7.72-0.08-1.0%7.857.957.5871,198
7.80-0.32-3.9%8.068.167.8077,016
8.12-0.06-0.7%8.208.237.9071,490
8.18+0.13+1.6%8.058.617.90121,269
8.05-0.09-1.1%8.158.457.92128,984
8.14+0.52+6.8%7.708.457.64215,847
7.62-2.84-27.2%9.449.507.61684,984
10.46-0.30-2.8%10.7610.9410.4449,792
10.76-0.48-4.3%11.3811.3810.7432,791
11.24+0.18+1.6%11.1411.5611.0284,406
11.06-0.18-1.6%11.2011.2010.52150,962
11.24+0.10+0.9%11.2611.5411.0443,198
11.14+0.28+2.6%11.0011.1810.70118,893
10.86-0.10-0.9%10.8011.1210.7017,569
10.96+0.16+1.5%10.9411.1410.6450,704
10.80-0.26-2.4%11.1211.1210.7251,581
11.06-0.28-2.5%11.1011.5010.8632,543
11.34-0.06-0.5%11.5011.5011.1057,061
11.40-0.44-3.7%11.9611.9611.2845,514
11.84-0.30-2.5%12.2012.2011.8024,377
12.14+0.38+3.2%11.8012.4611.4855,294
11.76-0.26-2.2%11.9011.9811.7038,638
12.02-0.36-2.9%12.5012.5011.9247,501
12.38+0.10+0.8%12.2012.7812.1036,662
12.28+0.10+0.8%12.1012.5812.1043,045
12.18-0.16-1.3%12.2212.3011.8665,868
12.34-0.02-0.2%12.3012.4412.1038,643
12.36-0.24-1.9%12.7812.8012.1830,641
12.60+0.38+3.1%12.2212.7012.2249,333
12.22-0.26-2.1%12.6012.7012.2026,028
12.48+0.28+2.3%12.2012.6012.2021,195
12.20-0.34-2.7%12.6012.6012.1035,206
12.54-0.04-0.3%12.5612.6412.2033,073
12.58-0.38-2.9%13.0013.4412.3086,719
12.96+0.16+1.3%12.9013.2412.6049,841
12.80+0.06+0.5%12.7012.9812.6243,534
12.74+0.32+2.6%12.5413.2212.4249,884
12.42-0.52-4.0%13.0013.0012.4067,947
12.94+1.22+10.4%12.3013.1012.08103,203
11.72-0.04-0.3%11.8411.9211.6455,791
11.76-0.14-1.2%12.0812.2211.7222,599
11.90-0.32-2.6%12.1812.4011.9019,884
12.22-0.08-0.7%12.2812.6412.2024,467
12.30+0.04+0.3%12.3013.0012.28100,553
12.26+0.44+3.7%11.9412.3811.8869,429
11.82+0.22+1.9%11.5012.0611.5045,030
11.60-0.06-0.5%11.9811.9811.4846,750
Ticker
BX Swiss:NWRN
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
BX Swiss
Currency
CHF

What changed lately

Calls

Replays

  • Newron Pharmaceuticals (SIX Swiss: NWRN) Q4 2025 Earnings Call

    Tue, Mar 24, 2026 · 9:30 AM ET

    Watch Transcript

Latest news

Newron Completes Enrollment of Pivotal Phase 3 ENIGMA-TRS 1 Study

Oct 22, 2026

Closed 8.68 (+2.1%) on Oct 22, 2026

Newron presents H1 2026 results and provides corporate update

Sep 22, 2026

Closed 11.06 (-1.6%) on Sep 22, 2026

Newron Pharmaceuticals S p A presents H1 2026 results and provides corporate update

Sep 22, 2026

Closed 11.06 (-1.6%) on Sep 22, 2026

Newron Reports Subscription for EUR 5.5 Million of Shares by Investor Group as Part of Up to EUR 38 Million Total Financing to Advance Phase 3 Evenamide Program

Sep 8, 2026

Closed 12.14 (+3.2%) on Sep 8, 2026

Newron Pharmaceuticals to Participate in H.C. Wainwright 28th Annual Global Investment Conference

Sep 3, 2026

Closed 12.38 (+0.8%) on Sep 3, 2026

Newron announces completion of screening for enrollment in pivotal Phase 3 ENIGMA-TRS 1 study with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS)

Sep 2, 2026

Closed 12.28 (+0.8%) on Sep 2, 2026

Newron Provides Update Following Type A Meeting With the FDA

Jul 2, 2026

Closed 12.20 (-4.4%) on Jul 3, 2026

Newron Pharmaceuticals to Participate in June Investor Conferences

May 28, 2026

Closed 14.56 (+2.7%) on May 28, 2026

Newron Reports a Pause of Enrollment of New Study Participants in US Centers of ENIGMA-TRS 2 Study

Apr 29, 2026

Closed 14.30 (-3.4%) on Apr 30, 2026

Newron Announces AGM 2026 Results

Apr 23, 2026

Closed 15.58 (-5.1%) on Apr 24, 2026

All Newron Pharmaceuticals S.p.A. news

Financings

  • Private placement of newly issued shares

    Sep 22, 2026

    Tranche closed: €20.5M raised

    Use of proceeds: Strengthen financial position and support continued execution of the ENIGMA-TRS Phase 3 program for evenamide

    Tranche closed Sep 8, 2026 · Tranche closed Sep 22, 2026

Read by 6ix AI from the company's releases

Decks

Newron Pharmaceuticals S.p.A. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
24 in the last 12 months · 33 in all · newest Oct 22, 2026 · oldest 2025
Calls
1 call with a replay · 1 with a transcript · latest Mar 24, 2026
Decks
15 decks · latest Mar 24, 2026

Where Newron Pharmaceuticals S.p.A. is listed

ListingExchangeCountryCurrency
SIX Swiss:NWRN · Home listingSIX SwissSwitzerlandCHF
Xetra:NP5XetraGermanyEUR
gettex:NP5gettexGermanyEUR
LS Exchange:A0LF18LS ExchangeGermanyEUR
LSE:0QOILSEUnited KingdomCHF
Tradegate:NP5TradegateGermanyEUR
Lang & Schwarz:A0LF18Lang & SchwarzGermanyEUR
BX Swiss:NWRN · This pageBX SwissSwitzerlandCHF
OTC:NWPHFOTCUnited StatesUSD
Frankfurt:NP5FrankfurtGermanyEUR
Aquis:NWRNZAquisUnited KingdomCHF
Stuttgart:NP5StuttgartGermanyEUR
Hamburg:NP5HamburgGermanyEUR
Dusseldorf:NP5DusseldorfGermanyEUR
Munich:NP5MunichGermanyEUR
Turquoise:NWRNZTurquoiseUnited KingdomCHF
Hanover:NP5HanoverGermanyEUR

Log in to ask 6ix AI your own questions about Newron Pharmaceuticals S.p.A.